Intercept to Present at Upcoming Investor Conferences
August 29 2018 - 7:05AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that management will be presenting at the following
upcoming investor conferences:
- Baird 2018 Global Healthcare Conference at 10:50 a.m. ET on
Wednesday, September 5, 2018;
- 16th Annual Morgan Stanley Global Healthcare Conference at
11:05 a.m. ET on Friday, September 14, 2018.
Webcast information for these events will be available on the
investor page of Intercept’s website at
http://ir.interceptpharma.com. Archived webcasts will be available
on Intercept’s website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC), nonalcoholic
steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and
biliary atresia. Founded in 2002 in New York, Intercept has
operations in the United States, Europe and Canada.
CONTACT
For more information about Intercept, please contact:
Mark
Vignola
+1-646-747-1000
investors@interceptpharma.com
Media
inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Sep 2023 to Sep 2024